Kinome Array Profiling of Patient-Derived Pancreatic Ductal Adenocarcinoma Identifies Differentially Active Protein Tyrosine Kinases

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 Nov 20

PMID 33213062

Citations 18

Authors

Justin F Creeden

Khaled Alganem

Ali S Imami

F Charles Brunicardi

Shi-He Liu

Rammohan Shukla

Tushar Tomar

Faris Naji

Robert E McCullumsmith

Affiliations

Soon will be listed here.

Abstract

Pancreatic cancer remains one of the most difficult malignancies to treat. Minimal improvements in patient outcomes and persistently abysmal patient survival rates underscore the great need for new treatment strategies. Currently, there is intense interest in therapeutic strategies that target tyrosine protein kinases. Here, we employed kinome arrays and bioinformatic pipelines capable of identifying differentially active protein tyrosine kinases in different patient-derived pancreatic ductal adenocarcinoma (PDAC) cell lines and wild-type pancreatic tissue to investigate the unique kinomic networks of PDAC samples and posit novel target kinases for pancreatic cancer therapy. Consistent with previously described reports, the resultant peptide-based kinome array profiles identified increased protein tyrosine kinase activity in pancreatic cancer for the following kinases: epidermal growth factor receptor (EGFR), fms related receptor tyrosine kinase 4/vascular endothelial growth factor receptor 3 (FLT4/VEGFR-3), insulin receptor (INSR), ephrin receptor A2 (EPHA2), platelet derived growth factor receptor alpha (PDGFRA), SRC proto-oncogene kinase (SRC), and tyrosine kinase non receptor 2 (TNK2). Furthermore, this study identified increased activity for protein tyrosine kinases with limited prior evidence of differential activity in pancreatic cancer. These protein tyrosine kinases include B lymphoid kinase (BLK), Fyn-related kinase (FRK), Lck/Yes-related novel kinase (LYN), FYN proto-oncogene kinase (FYN), lymphocyte cell-specific kinase (LCK), tec protein kinase (TEC), hemopoietic cell kinase (HCK), ABL proto-oncogene 2 kinase (ABL2), discoidin domain receptor 1 kinase (DDR1), and ephrin receptor A8 kinase (EPHA8). Together, these results support the utility of peptide array kinomic analyses in the generation of potential candidate kinases for future pancreatic cancer therapeutic development.

Citing Articles

Insulin receptor responsiveness governs TGFβ-induced hepatic stellate cell activation: Insulin resistance instigates liver fibrosis.

Lee W, Bates E, Kipp Z, Pauss S, Martinez G, Blair C FASEB J. 2025; 39(5):e70427.

PMID: 40022609 PMC: 11871568. DOI: 10.1096/fj.202402169R.

Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic Approaches.

Xu Y, Peng X, East M, McCabe I, Stroman G, Jenner M Cancer Discov. 2024; 15(2):346-362.

PMID: 39632628 PMC: 11805639. DOI: 10.1158/2159-8290.CD-23-1480.

Illuminating the dark kinome: utilizing multiplex peptide activity arrays to functionally annotate understudied kinases.

Hamoud A, Alganem K, Hanna S, Morran M, Henkel N, Imami A Cell Commun Signal. 2024; 22(1):501.

PMID: 39415254 PMC: 11484317. DOI: 10.1186/s12964-024-01868-4.

Nanoformulation of dasatinib cannot overcome therapy resistance of pancreatic cancer cells with low LYN kinase expression.

Kaul M, Sanin A, Shi W, Janiak C, Kahlert U Pharmacol Rep. 2024; 76(4):793-806.

PMID: 38739359 PMC: 11294441. DOI: 10.1007/s43440-024-00600-w.

Neuronal alterations in AKT isotype expression in schizophrenia.

Devine E, Imami A, Eby H, Hamoud A, Golchin H, Ryan W Res Sq. 2024; .

PMID: 38559131 PMC: 10980160. DOI: 10.21203/rs.3.rs-3940448/v1.

References

Xue Y, Liu Z, Cao J, Ma Q, Gao X, Wang Q . GPS 2.1: enhanced prediction of kinase-specific phosphorylation sites with an algorithm of motif length selection. Protein Eng Des Sel. 2010; 24(3):255-60. DOI: 10.1093/protein/gzq094. View

Schrode N, Ho S, Yamamuro K, Dobbyn A, Huckins L, Matos M . Synergistic effects of common schizophrenia risk variants. Nat Genet. 2019; 51(10):1475-1485. PMC: 6778520. DOI: 10.1038/s41588-019-0497-5. View

McGuire J, DePasquale E, Funk A, ODonnovan S, Hasselfeld K, Marwaha S . Abnormalities of signal transduction networks in chronic schizophrenia. NPJ Schizophr. 2017; 3(1):30. PMC: 5595970. DOI: 10.1038/s41537-017-0032-6. View

Liu S, Ballian N, Belaguli N, Patel S, Li M, Templeton N . PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer. Pancreas. 2008; 37(2):210-20. DOI: 10.1097/MPA.0b013e31816a4a33. View

Ahn K, O Y, Ji Y, Cho H, Lee D . Synergistic Anti-Cancer Effects of AKT and SRC Inhibition in Human Pancreatic Cancer Cells. Yonsei Med J. 2018; 59(6):727-735. PMC: 6037593. DOI: 10.3349/ymj.2018.59.6.727. View

Britton D, Zen Y, Quaglia A, Selzer S, Mitra V, LoBner C . Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets. PLoS One. 2014; 9(3):e90948. PMC: 3966770. DOI: 10.1371/journal.pone.0090948. View

Flaherty E, Zhu S, Barretto N, Cheng E, Deans P, Fernando M . Neuronal impact of patient-specific aberrant NRXN1α splicing. Nat Genet. 2019; 51(12):1679-1690. PMC: 7451045. DOI: 10.1038/s41588-019-0539-z. View

Dorsett C, McGuire J, Niedzielko T, DePasquale E, Meller J, Floyd C . Traumatic Brain Injury Induces Alterations in Cortical Glutamate Uptake without a Reduction in Glutamate Transporter-1 Protein Expression. J Neurotrauma. 2016; 34(1):220-234. PMC: 5198172. DOI: 10.1089/neu.2015.4372. View

Manning G, Whyte D, Martinez R, Hunter T, Sudarsanam S . The protein kinase complement of the human genome. Science. 2002; 298(5600):1912-34. DOI: 10.1126/science.1075762. View

10.

Wu X, Zahari M, Renuse S, Kelkar D, Barbhuiya M, Rojas P . The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer. Oncotarget. 2016; 8(2):2971-2983. PMC: 5356856. DOI: 10.18632/oncotarget.13579. View

11.

Mahajan K, Mahajan N . ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers. Oncogene. 2014; 34(32):4162-7. PMC: 4411206. DOI: 10.1038/onc.2014.350. View

12.

Payankaulam S, Raicu A, Arnosti D . Transcriptional Regulation of , the Insulin Receptor Gene. Genes (Basel). 2019; 10(12). PMC: 6947883. DOI: 10.3390/genes10120984. View

13.

Torsello B, De Marco S, Bombelli S, Chisci E, Cassina V, Corti R . The 1ALCTL and 1BLCTL isoforms of Arg/Abl2 induce fibroblast activation and extra cellular matrix remodelling differently. Biol Open. 2019; 8(3). PMC: 6451347. DOI: 10.1242/bio.038554. View

14.

Krug K, Mertins P, Zhang B, Hornbeck P, Raju R, Ahmad R . A Curated Resource for Phosphosite-specific Signature Analysis. Mol Cell Proteomics. 2018; 18(3):576-593. PMC: 6398202. DOI: 10.1074/mcp.TIR118.000943. View

15.

Xie L, Kassner M, Munoz R, Que Q, Kiefer J, Zhao Y . Kinome-wide siRNA screening identifies molecular targets mediating the sensitivity of pancreatic cancer cells to Aurora kinase inhibitors. Biochem Pharmacol. 2011; 83(4):452-61. PMC: 3265162. DOI: 10.1016/j.bcp.2011.11.005. View

16.

Richter H, Satz A, Bedoucha M, Buettelmann B, Petersen A, Harmeier A . DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome. ACS Chem Biol. 2018; 14(1):37-49. PMC: 6343110. DOI: 10.1021/acschembio.8b00866. View

17.

Knosel T, Chen Y, Altendorf-Hofmann A, Danielczok C, Freesmeyer M, Settmacher U . High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event. J Cancer Res Clin Oncol. 2011; 138(3):397-403. DOI: 10.1007/s00432-011-1107-9. View

18.

Philipsen L, Reddycherla A, Hartig R, Gumz J, Kastle M, Kritikos A . De novo phosphorylation and conformational opening of the tyrosine kinase Lck act in concert to initiate T cell receptor signaling. Sci Signal. 2017; 10(462). DOI: 10.1126/scisignal.aaf4736. View

19.

Yamanaka Y, Friess H, Kobrin M, Buchler M, Beger H, Korc M . Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Res. 1993; 13(3):565-9. View

20.

Wei T, Zhang L, Lv Y, Ma X, Zhi L, Liu C . Overexpression of platelet-derived growth factor receptor alpha promotes tumor progression and indicates poor prognosis in hepatocellular carcinoma. Oncotarget. 2014; 5(21):10307-17. PMC: 4279374. DOI: 10.18632/oncotarget.2537. View